Page 1 | Search Results | Blood | American Society of Hematology

1-18 of 18

Sort by

Sort Order Select

Journal Articles

Prophylaxis of Chemotherapy-Induced Nausea and Vomiting with Fosaprepitant and Granisetron in Pediatric Patients after Allogeneic HSCT

Karin Melanie Cabanillas Stanchi, MSc, Julia Vek, Dr. MD, Patrick Schlegel, MD, Christian M. Seitz, MD, Joachim Rupprecht, Dr. MD, Sarah Schober, Dr. MD, Sebastian Michaelis, Dr. MD, Carmen Malaval, Dr. MD, Tim Flaadt, Dr. MD, Lukas Schnaufer, Dr. MD, Manon Queudeville, Dr. MD, Judith Feucht, Dr. MD, Peter Lang, MD, Rupert Handgretinger, MD PhD, Michaela Döring, Dr. MD

Blood (2018) 132 (Supplement 1): 3388.

https://doi.org/10.1182/blood-2018-99-112762

Published: 2018

Journal Articles

Antiemetic Prophylaxis with Granisetron and Fosaprepitant during Moderate and High Emetogenic Chemotherapy in Pediatric Patients

Michaela Döring, Dr. MD, Karin Melanie Cabanillas Stanchi, MSc, Manon Queudeville, Dr. MD, Ulrike Hartmann, Dr., Michael Ost, Dr. MD, Marie-Sarah Koch, Dr. MD, Carmen Malaval, Dr. MD, Markus Mezger, Dr. MD Dr. rer. nat., Sarah Schober, Dr. MD, Simone Weber, Dr. MD, Veit Lange, Dr. MD, Rupert Handgretinger, MD, Martin Ebinger, MD

Blood (2017) 130 (Supplement 1): 3228.

https://doi.org/10.1182/blood.V130.Suppl_1.3228.3228

Published: 2017

Journal Articles

Pharmacokinetic Analysis during Antifungal Prophylaxis with Posaconazole Suspension in Pediatric and Adolescent Patients after Allogeneic Hematopoietic Stem Cell Transplantation

Michaela Döring, MD, Karin Melanie Cabanillas Stanchi, Manon Queudeville, MD, Judith Feucht, MD, Patrick Schlegel, MD, Tobias Feuchtinger, MD, Peter Lang, MD, Rupert Handgretinger, Prof. MD, Werner J. Heinz, MD

Blood (2015) 126 (23): 4338.

https://doi.org/10.1182/blood.V126.23.4338.4338

Published: 2015

Journal Articles

Leukemia Initiating Cells In Acute Lymphoblastic Leukemia Are Characterized By Low Metabolic Activity and Enriched In Early Cell Cycle

Luca Trentin, PhD, Manon Queudeville, MD, Sarah M Eckhoff, MD, Manuel Herrmann, Simone Miller, Sandra Lutz, Nabiul Hasan, Klaus-Michael Debatin, MD PhD, Lueder H Meyer, MD PhD

Blood (2013) 122 (21): 4197.

https://doi.org/10.1182/blood.V122.21.4197.4197

Published: 2013

Journal Articles

Overcoming Apoptosis Resistance In High Risk Acute Lymphoblastic Leukemia By Smac Mimetics In a Preclinical ALL Xenograft Model In Vivo

Melanie Schirmer, MD, Manon Queudeville, MD, Luca Trentin, PhD, Sarah M Eckhoff, MD, Lueder H Meyer, MD, PhD, Klaus-Michael Debatin, MD, PhD

Blood (2013) 122 (21): 1433.

https://doi.org/10.1182/blood.V122.21.1433.1433

Published: 2013

Journal Articles

CRLF2 Rearrangement Is Not Associated with Activated mTOR Pathway in NOD/SCID/huALL Xenograft Mouse Model.

Md. Nabiul Hasan, MSc, Silvia Bresolin, PhD, Ilaria Bronzini, PhD, Chiara Palmi, PhD, Manon Queudeville, MD, Sarah Mirjam Eckhoff, MD, Luca Trentin, PhD, Giovanni Cazzaniga, PhD, Geertury te Kronnie, PhD, Klaus-Michael Debatin, MD, PhD, Lüder-Hinrich Meyer, MD

Blood (2012) 120 (21): 2518.

https://doi.org/10.1182/blood.V120.21.2518.2518

Published: 2012

Journal Articles

Rapid BCP-ALL Engraftment in NOD/SCID Mice Is Characterized by a High Leukemia Initiating Cell (LIC) Frequency.

Luca Trentin, PhD, Manon Queudeville, MD, Sarah M. Eckhoff, MD, Felix Seyfried, Manuel Herrmann, Simone Miller, Nabiul Hasan, Klaus-Michael Debatin, MD, PhD, Lueder H. Meyer, MD

Blood (2012) 120 (21): 2985.

https://doi.org/10.1182/blood.V120.21.2985.2985

Published: 2012

Journal Articles

Hyperactivated mTOR Signaling Is a Characteristic Feature of High Risk Acute Lymphoblastic Leukemia and Can Be Effectively Targeted in a Preclinical NOD/SCID/huALL Xenograft Mouse Model

Md. Nabiul Hasan, MSc, Manon Queudeville, MD, Sarah Mirjam Eckhoff, MD, Manuel Herrmann, Simone Miller, Luca Trentin, PhD, Klaus-Michael Debatin, MD PhD, Lueder Hinrich Meyer, MD

Blood (2011) 118 (21): 2572.

https://doi.org/10.1182/blood.V118.21.2572.2572

Published: 2011

Journal Articles

High Risk Acute Lymphoblastic Leukemia with Rapid NOD/SCID Engraftment Is Characterized by High Protein Expression of CYCLIN B, Beta-CATENIN, ANNEXIN I and Decreased PKC Alpha Activation

Felix Seyfried, Benedetta Accordi, PhD, Manon Queudeville, MD, Sarah Mirjam Eckhoff, MD, Gloria Milani, Luisa Galla, Marco Giordan, PhD, Johann M Kraus, Giuseppe Basso, MD PhD, Hans Armin Kestler, PhD, Geertruy te Kronnie, PhD, Klaus-Michael Debatin, MD, PhD, Lueder Hinrich Meyer, MD

Blood (2011) 118 (21): 1457.

https://doi.org/10.1182/blood.V118.21.1457.1457

Published: 2011

Journal Articles

Activation of Acute Lymphocytic Leukemia Blasts with CpG ODN, IL-4 and CD40 Ligand Facilitates Enhanced Anti-Leukemic CTL Responses

Dorit Fabricius, Lucia Breckerbohm, Manon Queudeville, MD, Angelika Vollmer, Sarah M. Eckhoff, MD, Johanna Pfeil, Gudrun Strauss, PhD, Simone Fulda, MD, Bernd Jahrsdoerfer, MD, Lueder H Meyer, MD, Klaus-Michael Debatin, MD

Blood (2010) 116 (21): 3907.

https://doi.org/10.1182/blood.V116.21.3907.3907

Published: 2010

Journal Articles

Intact Apoptosis Signaling In Pediatric ALL Xenograft Leukemia Is Associated with Favorable Patient Outcome, Prolonged NOD/SCID Engraftment and Low Expression of Anti-Apoptotic Molecules

Manon Queudeville, Felix Seyfried, Sarah Mirjam Eckhoff, Klaus-Michael Debatin, MD, Lueder Hinrich Meyer

Blood (2010) 116 (21): 2722.

https://doi.org/10.1182/blood.V116.21.2722.2722

Published: 2010

Journal Articles

Single-Cell Phospho-Profiling in Pediatric B-Cell Precursor Acute Lymphoblastic Leukemia Reveals Signaling Differences in Cytogenetic and Prognostic Subgroups.

Manon Queudeville, MD, Sarah M. Eckhoff, MD, Klaus-Michael Debatin, MD, Lueder H. Meyer, MD

Blood (2009) 114 (22): 2653.

https://doi.org/10.1182/blood.V114.22.2653.2653

Published: 2009

Journal Articles

Xenografts of Pediatric Acute Lymphoblastic Leukemia Retain the Gene Expression Pattern From the Diagnostic Material They Originated From Over Serial Passages.

Manon Queudeville, MD, Elena Vendramini, Marco Giordan, PhD, Sarah M. Eckhoff, MD, Giuseppe Basso, MD, Klaus-Michael Debatin, MD, Truus Te Kronnie, PhD, Lueder H. Meyer, MD

Blood (2009) 114 (22): 1629.

https://doi.org/10.1182/blood.V114.22.1629.1629

Published: 2009

Journal Articles

A Novel B Cell Precursor ALL Cell Line (018Z) with Prominent Neurotropism and Isolated CNS Leukemia in a NOD/SCID/huALL Xenotransplantation Model.

Eckhoff M. Eckhoff, MD, Manon Queudeville, MD, Klaus-Michael Debatin, MD, Lueder H. Meyer, MD

Blood (2009) 114 (22): 1630.

https://doi.org/10.1182/blood.V114.22.1630.1630

Published: 2009

Journal Articles

Deficient Apoptosis Signaling in Primary Pediatric BCP-ALL Xenograft Cells Determines the Kinetic of Engraftment in Vivo in a NOD/SCID Model and Patient Outcome

Manon Queudeville, MD, Sarah M. Eckhoff, MD, Karsten Stahnke, MD, Klaus-Michael Debatin, MD, Lueder H. Meyer, MD

Blood (2008) 112 (11): 2509.

https://doi.org/10.1182/blood.V112.11.2509.2509

Published: 2008

Journal Articles

Single-Cell Phospho-Profiling in Pediatric Acute Lymphoblastic Leukemia (ALL) Reveals Constitutive and Cytokine Induced Specific Signatures Involving Stat5

Manon Queudeville, MD, Hannah Kunze, Sarah M. Eckhoff, MD, Klaus-Michael Debatin, MD, Lueder H. Meyer, MD

Blood (2008) 112 (11): 2511.

https://doi.org/10.1182/blood.V112.11.2511.2511

Published: 2008

Journal Articles

Time to Leukemia (TTL) in NOD/SCID Mice Determines Patient Outcome and Is Characterized by a 5 Genes Signature Associated with Relapse

Lueder Hinrich Meyer, MD, Andrea Zangrando, PhD, Sarah M. Eckhoff, MD, Manon Queudeville, MD, Elena Vendramini, Giuseppe Basso, MD, Geertruy te Kronnie, PhD, Klaus-Michael Debatin, MD

Blood (2008) 112 (11): 755.

https://doi.org/10.1182/blood.V112.11.755.755

Published: 2008

Journal Articles

Intact apoptosis signaling in myeloid leukemia cells determines treatment outcome in childhood AML

Lüder H. Meyer, Manon Queudeville, Sarah M. Eckhoff, Ursula Creutzig, Dirk Reinhardt, Leonid Karawajew, Wolf-Dieter Ludwig, Karsten Stahnke, Klaus-Michael Debatin

Blood (2008) 111 (5): 2899–2903.

https://doi.org/10.1182/blood-2007-08-109058

Published: 2008

Includes: Supplemental data

NARROW

Prophylaxis of Chemotherapy-Induced Nausea and Vomiting with Fosaprepitant and Granisetron in Pediatric Patients after Allogeneic HSCT

Antiemetic Prophylaxis with Granisetron and Fosaprepitant during Moderate and High Emetogenic Chemotherapy in Pediatric Patients

Pharmacokinetic Analysis during Antifungal Prophylaxis with Posaconazole Suspension in Pediatric and Adolescent Patients after Allogeneic Hematopoietic Stem Cell Transplantation

Leukemia Initiating Cells In Acute Lymphoblastic Leukemia Are Characterized By Low Metabolic Activity and Enriched In Early Cell Cycle

Overcoming Apoptosis Resistance In High Risk Acute Lymphoblastic Leukemia By Smac Mimetics In a Preclinical ALL Xenograft Model In Vivo

CRLF2 Rearrangement Is Not Associated with Activated mTOR Pathway in NOD/SCID/huALL Xenograft Mouse Model.

Rapid BCP-ALL Engraftment in NOD/SCID Mice Is Characterized by a High Leukemia Initiating Cell (LIC) Frequency.

Hyperactivated mTOR Signaling Is a Characteristic Feature of High Risk Acute Lymphoblastic Leukemia and Can Be Effectively Targeted in a Preclinical NOD/SCID/huALL Xenograft Mouse Model

High Risk Acute Lymphoblastic Leukemia with Rapid NOD/SCID Engraftment Is Characterized by High Protein Expression of CYCLIN B, Beta-CATENIN, ANNEXIN I and Decreased PKC Alpha Activation

Activation of Acute Lymphocytic Leukemia Blasts with CpG ODN, IL-4 and CD40 Ligand Facilitates Enhanced Anti-Leukemic CTL Responses

Intact Apoptosis Signaling In Pediatric ALL Xenograft Leukemia Is Associated with Favorable Patient Outcome, Prolonged NOD/SCID Engraftment and Low Expression of Anti-Apoptotic Molecules

Single-Cell Phospho-Profiling in Pediatric B-Cell Precursor Acute Lymphoblastic Leukemia Reveals Signaling Differences in Cytogenetic and Prognostic Subgroups.

Xenografts of Pediatric Acute Lymphoblastic Leukemia Retain the Gene Expression Pattern From the Diagnostic Material They Originated From Over Serial Passages.

A Novel B Cell Precursor ALL Cell Line (018Z) with Prominent Neurotropism and Isolated CNS Leukemia in a NOD/SCID/huALL Xenotransplantation Model.

Deficient Apoptosis Signaling in Primary Pediatric BCP-ALL Xenograft Cells Determines the Kinetic of Engraftment in Vivo in a NOD/SCID Model and Patient Outcome

Single-Cell Phospho-Profiling in Pediatric Acute Lymphoblastic Leukemia (ALL) Reveals Constitutive and Cytokine Induced Specific Signatures Involving Stat5

Time to Leukemia (TTL) in NOD/SCID Mice Determines Patient Outcome and Is Characterized by a 5 Genes Signature Associated with Relapse

Intact apoptosis signaling in myeloid leukemia cells determines treatment outcome in childhood AML

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only